Intec Pharma acknowledged with patent

Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordio...

January 8, 2018 | Monday | Regulatory
Pfizer to launch a new venture fund to invest in neuroscience research projects

The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating...

January 8, 2018 | Monday | News
Drug for diabetes type 2 shows potential in treating Alzheimer’s

According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly b...

January 4, 2018 | Thursday | News
Biocon & Mylan's biosimilar gets Brazilian approval

The biosimilar trastuzumab has been approved by ANVISA, the Brazilian regulatory agency. Co-developed by Biocon and...

December 29, 2017 | Friday | News
FDA approves drug to treat dangerously low blood pressure

Singapore - The U.S. Food and Drug Administration approved Giapreza (angiotensin II) injection for intravenous infusion ...

December 27, 2017 | Wednesday | News
Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market

Dr. Reddy’s Laboratories Ltd has announced that it has launched Melphalan Hydrochloride for Injection which is a t...

December 27, 2017 | Wednesday | News
CANbridge submits investigational new drug application for cancer treatment

CANbridge Life Sciences is a bio-pharmaceutical company accelerating development and commercialization of specialty heal...

December 27, 2017 | Wednesday | News
Otsuka collaborates with X-Chem for new drug compounds

US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...

December 26, 2017 | Tuesday | News
Adaptive Phase II Study of BAN2401 in Early Alzheimer’s Disease Continues toward 18-Month Endpoint

Eisai Co., Ltd. and Biogen Inc. has announced that an Independent Data Monitoring Committee has determined that BAN2401,...

December 22, 2017 | Friday | News
Confo Therapeutics enters into collaboration with Roche

Drug Discovery company, Confo Therapeutics has announced that it has entered into a research collaboration and license a...

December 20, 2017 | Wednesday | News
Researchers show patients' own immune cells can fight deadly cancers

Singapore - Scientists have taken a significant step forward in efforts to harness our own white blood cells to fight de...

December 15, 2017 | Friday | News
Bioelectronic medicine to treat lupus

Singapore - Researchers at Northwell Health's Feinstein Institute for Medical Research are conducting a clinic...

December 15, 2017 | Friday | News
Sirenas receives $1.68 M research grant to accelerate ATLANTIS

Singapore – Sirenas, a biotechnology company harnessing computational approaches to discover therapeutics derived ...

December 13, 2017 | Wednesday | News
Kenalog-40 Injection approved and available through Amneal Biosciences

Singapore - Amneal Biosciences (a US based pharmaceutical manufacturing company) received approval for its Triamcin...

December 13, 2017 | Wednesday | News
FDA approves Sanofi's Admelog

Singapore - The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog, the first follow-on insulin lispr...

December 13, 2017 | Wednesday | News
JW Pharma releases cancer treatment trial results

South Korea based JW Pharmaceuticals recently presented phase 1a/1b clinical trial results for CWP291, a target anticanc...

December 12, 2017 | Tuesday | News
Sanofi ends development of Clostridium difficile vaccine

The pharma giant Sanofi has recently announced that it will terminate its late-stage program for a Clostridium difficile...

December 5, 2017 | Tuesday | News
Pfizer inks drug development and commercialization deal with Basilea Pharma

Global pharmaceutical giant Pfizer has inked a strategic deal with Basilea Pharmaceutical, an international biopharmaceu...

December 1, 2017 | Friday | News
Achievement of Biotech Company: Treat Burns with Pineapples

Nasdaq-listed, Israel-headquartered biotechnology company MediWound Ltd. is attempting to revolutionize the way doctors ...

November 27, 2017 | Monday | News
Khondrion presents Phase II KHENERGY trial data

Clinical stage pharma company, Khondrion focusing on small molecule therapeutics for mitochondrial diseases has announce...

November 23, 2017 | Thursday | News
Novel in vitro model investigates drug candidates for cancer metastasis

Singapore - ATCC, an established and trusted source of biological materials in the R&D community, announced the rele...

November 22, 2017 | Wednesday | News
Gamida Cell appoints Julian Adams as chairman and CEO

Cellular and immune therapeutics company, Gamida Cell has announced the appointment of Julian Adams as chairman and chie...

November 21, 2017 | Tuesday | News
NDA submission for Starpharma’s VivaGel BV

Singapore - Australian biotech company Starpharma submitted its New Drug Application (NDA) with the US FDA through a rol...

November 21, 2017 | Tuesday | News
Mitsubhishi Tanabe Pharma's ALS drug treats more than 1000 people in three months

Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic latera...

November 17, 2017 | Friday | News
Seres Therapeutics, MD Anderson Cancer Center and Parker Institute for Cancer Immunotherapy collaborates

Seres Therapeutics, The University of Texas MD Anderson Cancer Center (MD Anderson), and the Parker Institute ...

November 15, 2017 | Wednesday | News
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies

Life Science company Bayer has entered into an exclusive global collaboration with US based biopharma company Loxo Oncol...

November 15, 2017 | Wednesday | News
Korea's Dongsung Pharmaceuticals opens a new cancer research center in Seoul

In a bid to further strengthen its pipeline of cancer treatments, Korea’s Dongsung Pharmaceuticals has recently op...

November 14, 2017 | Tuesday | News
Helperby Therapeutics develops sustainable solution for antibiotic resistance

UK based pharma company, Helperby Therapeutics has developed Antibiotic Resistance Breakers (ARBs) as a solution to the ...

November 13, 2017 | Monday | News
Amgen And Novartis announce expanded collaboration with Banner Alzheimer's Institute

Singapore – Amgen and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to ...

November 3, 2017 | Friday | News
Boehringer Ingelheim and Dicerna collaborate to develop treatments for chronic liver diseases

Pharma company Boehringer Ingelheim and leading developer of RNAi therapeutics Dicerna Pharmaceuticals has announced a r...

November 2, 2017 | Thursday | News
Evolution of drug delivery system for better patient safety

Chronic conditions such as diabetes, multiple sclerosis and rheumatoid arthritis are on the rise and often require daily...

November 1, 2017 | Wednesday | News
CFDA accepts Eisai's NDA for cancer drug

 Eisai Co., Ltd. announced that the China Food and Drug Administration (CFDA) has accepted for review a New Drug Ap...

October 31, 2017 | Tuesday | News
New 'Double Decker' Antibody Technology Fights Cancer 

Singapore - Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created...

October 26, 2017 | Thursday | News
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine 

Singapore - Alopexx Vaccine LLC (a US- based science driven investment company) announced that it has completed a Phase ...

October 26, 2017 | Thursday | News
Incyte and MacroGenics collaborates for anti-PD-1 monoclonal antibody

Biopharma company, Incyte Corporation and MacroGenics has announced that the companies have entered into an exclusi...

October 26, 2017 | Thursday | News
AbbVie plows $205M upfront Into Alector's Alzheimer's Program

AbbVie announced a strategic collaboration with South San Francisco-based Alector to develop and commercialize drugs for...

October 25, 2017 | Wednesday | News
Eisai, Biogen expand their agreement to codevelop and commercialize AD drug

  Japan’s Eisai and US based Biogen announced the expansion  of their existing collaboration agreement ...

October 24, 2017 | Tuesday | News
“With the new blood testing technology, the laboratories can better focus their resources and expertise.”

Q. Can you briefly explain this new blood testing technology and how is it different from the more conventional tests th...

October 13, 2017 | Friday | Opinion
Novel bi-specific antibody shows strong therapeutic potential to treat Zika virus infection

Singapore - The Journal Cell published data with a bi-specific antibody against Zika virus infection. The article is ent...

October 12, 2017 | Thursday | News
Adult patients with Schizophrenia in Singapore to benefit from the first three-monthly long-acting treatment

Singapore – Johnson & Johnson (J&J) announced the launch of its three-monthly long-acting treatment for sc...

October 10, 2017 | Tuesday | News
Chiome Bioscience selects ProBioGen for GlymaxX antibody manufacturing program

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins and Chiome Bioscience In...

October 5, 2017 | Thursday | News
Regulatory approval in Europe granted for Synthon's Glatiramer Acetate

Synthon announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-fi...

October 5, 2017 | Thursday | News
Sato And Eisai Pharma co-promote antifungal agent in Japan

Sato Pharmaceutical Co. Ltd., Eisai Co. Ltd., and Seren Pharmaceuticals Inc. announced that Sato Pharma and Eisai will c...

October 3, 2017 | Tuesday | News
Korea to inject 500 billion won into pharma sector; aims to launch 100 new drugs by 2026

 In  a bid to place Korea on the biotech global map, the Korean government announced plans to will inject 500 ...

September 30, 2017 | Saturday | News
Indivumed partners with cancer research specialist Helomics

Indivumed which has a large cancer biobank and Helomics Corporation (Helomics) has announced their collaboration to anal...

September 22, 2017 | Friday | News
GSK receives FDA nod for its triple drug inhaler

Bringing in much needed relief for patients suffering from Chronic Obstructive Pulmonary Disorder (COPD), the US FDA has...

September 21, 2017 | Thursday | News
Nacimbio signs agreement with MYLAN Laboratories

The National Immunobiological Company (Nacimbio) which is a part of Rostec State Corporation has signed an agreement wit...

September 19, 2017 | Tuesday | News
CSL Behring announces FDA approval of Privigen for the treatment of CIDP in adults

Global biotherapeutics leader CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved P...

September 15, 2017 | Friday | News
Bristol-Myers Squibb collaborates with ENHANZE technology

US based Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. has announced a global collaboration and lice...

September 15, 2017 | Friday | News
Invicro acquires Imanova to Expand Global Imaging Capabilities

Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discover...

September 12, 2017 | Tuesday | News
Boehringer collaborates with Gubra to develop next generation obesity treatments

Germany based Boehringer Ingelheim has committed up to €250 million ($300 million) to work with Gubra on ...

September 11, 2017 | Monday | News
Targeted therapy for acute myeloid leukemia

Singapore - The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), one of the de...

September 4, 2017 | Monday | News
Korean companies mull on using AI for drug discovery

In a bid to speed up drug discovery process and boost R&D efforts, Korea Pharmaceutical and Bio-pharma Manufacturers...

September 1, 2017 | Friday | News
FDA approved revolutionary immunotherapy for blood cancer patients

Singapore – The U.S. Food and Drug Administration (FDA) announced the approval of a new, cutting-edge gene therapy...

September 1, 2017 | Friday | News
New treatment for adults with relapsed or refractory acute lymphoblastic leukemia

Singapore- The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of ad...

August 18, 2017 | Friday | News
Swift announces the highest throughput single-cell methyl-seq library preparation method

Singapore - Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (N...

August 14, 2017 | Monday | News
Speeding up drug discovery process with Artificial Intelligence

Singapore: It’s estimated that, on average, to bring one new drug to the market can take 1,000 people, 12-15 years...

August 10, 2017 | Thursday | Opinion
Xarelto proven to be highly effective stroke prevention in patients with AF

Singapore - Cardiovascular diseases including heart diseases and stroke account for one-third of deaths (nearly 18 milli...

August 1, 2017 | Tuesday | News
Takeda, Tesaro ink strategic deal to co-develop and commercialize cancer drug

Japanese pharma giant Takeda pharmaceuticals has entered into a strategic licensing deal with US’s Tesaro  fo...

August 1, 2017 | Tuesday | News
CARB-X announces funding to speed treatments for the world’s deadliest super bugs

A year since launching, the international partnership CARB-X announced its second round of antibiotic research and ...

August 1, 2017 | Tuesday | News
Jim Spavins appointed to the advisory board of Catalent Applied Drug Delivery Institute

The Catalent Applied Drug Delivery Institute has announced Jim Spavins to their advisory board. He has over 36 years of...

July 31, 2017 | Monday | News
FROM TRADITIONAL TO ADVANCED: Drug delivery market on the growth curve in Asia

The field of drug delivery is highly interdisciplinary. This science of delivering a pharmaceutical compound in the huma...

July 26, 2017 | Wednesday | Analysis
Korean Pharma Association mulls on use of AI to speed drug discovery

Singapore: In a bid to spur the country’s drug development and research, South Korea’s leading biopharmaceu...

July 25, 2017 | Tuesday | News
FDA approves GSK’s new self-injectable formulation for systemic lupus erythematosus

Singapore - GSK announced that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulatio...

July 24, 2017 | Monday | News
FDA approves new treatment to reduce the risk of breast cancer returning

Singapore - The U.S. Food and Drug Administration approved Nerlynx (neratinib) for the extended adjuvant treatment of ea...

July 18, 2017 | Tuesday | News
U.S. FDA approves Janssen’s TREMFYA for the treatment of moderate to severe plaque psoriasis

Janssen Biotech, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved TREMFYA (guselkumab) for t...

July 17, 2017 | Monday | News
Kolon Life Science wins license for gene therapy drug

South Korea based Kolon Life Science has won a license to sell the nation’s first gene therapy drug for osteoarthr...

July 17, 2017 | Monday | News
Exscientia inks €37m contract with GSK

GlaxoSmithKline has secured access to Ex Scientia Ltd (Exscientia)’s artificial intelligence (AI)-driven drug...

July 3, 2017 | Monday | News
Promethazine by Strides Shasun approved by USFDA

Strides Shasun has recently received an approval from the United States Food & Drug Administration (USFDA) for Prome...

July 3, 2017 | Monday | News
Amgen’s uncontrolled LDL cholesterol lowering drug available in Singapore

Singapore – Amgen, a US based biotechnology company, announced the availability of Repatha(evolocumab), the first ...

July 3, 2017 | Monday | News
Strategic alliance between Alma Bio Therapeutics and Delphi Genetics on Plasmid DNA drugs

Alma Bio Therapeutics SAS (Alma) and Delphi Genetics SA recently announced that they are taking their strategic alliance...

June 27, 2017 | Tuesday | News
J&J’s type 2 diabetes drug INVOKANA significantly reduces major heart complications in CANVAS program

Singapore – Results from the landmark CANVAS Program showed INVOKANA (canagliflozin) significantly reduc...

June 27, 2017 | Tuesday | News
BioAuxilium completes development of its 100th TR-FRET assay kit

Canada based company BioAuxilium specialised in the development of custom TR-FRET assay kit recently announced the succe...

June 23, 2017 | Friday | News
Major advancement in cell-based influenza vaccine technology by Seqirus

Innovator in influenza vaccines and pandemic preparedness Seqirus recently announced the next major advancement in the u...

June 23, 2017 | Friday | News
New patent issuance for Zyga's SImmetry Sacroiliac Joint Fusion System

Singapore - Zyga Technology, Inc., a US based medical device company announced the issuance of a new US Patent represent...

June 22, 2017 | Thursday | News
New antibody for effective blood cancer treatment using two-pronged approach

Singapore- Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells direct...

June 22, 2017 | Thursday | News
Sunless tan now a reality!

Scientists have answered the woes of spending hours and hours on sunbeds to achieve the perfect bronzed tone. Better yet...

June 21, 2017 | Wednesday | News
A type-2 diabetes drug found to reduce heart and kidney risk

Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...

June 21, 2017 | Wednesday | News
Enzychem Lifesciences Announces Global Phase 2 Trial Inititation of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)

Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...

June 20, 2017 | Tuesday | News
NanoBio And Porton Biopharma receive approval to advance Anthrax Vaccine

NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...

June 20, 2017 | Tuesday | News
New, long-acting insulin therapy demonstrates Cardiovascular Safety

Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...

June 13, 2017 | Tuesday | News
A translational research collaboration

The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...

June 9, 2017 | Friday | News
BD Receives FDA 510(K) Clearance for Molecular Test of Acute Gastroenteritis.

Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...

June 5, 2017 | Monday | News
Trends in Drug Discovery Outsourcing: A Perspective

Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...

June 2, 2017 | Friday | Analysis
FDA approves new Novo Nordisk treatment for patients with Hemophilia

Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...

June 1, 2017 | Thursday | News
Biogen acquires Remedy Pharmaceuticals’ late stage drug CIRARA

Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...

May 23, 2017 | Tuesday | News
Symic Bio Secures $30 Million Series B financing 

Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...

May 23, 2017 | Tuesday | News
Sanofi enters into a $273 mn research deal with Exscientia

Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...

May 10, 2017 | Wednesday | News
FDA approves first new drug for ALS in 2 decades

After nearly two decades FDA has finally approved a drug for the treatment of amyotrophic lateral sclerosis (ALS). The d...

May 11, 2017 | Thursday | News
A new drug for diabetes

Indian scientists have found that a plant-derived substance called chalcone can be used to make an effective anti-diabet...

May 2, 2017 | Tuesday | News
Foamix Pharmaceuticals Ltd. completed Phase 3 trials for FMX101

Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing...

May 2, 2017 | Tuesday | News
Novel antibiotic resistance gene found in milk

According to the new study conducted by researchers of the University of Bern in Switzerland 'harmless' bacteria found i...

May 1, 2017 | Monday | News
Glenmark initiates clinical investigation for respiratory drug

Global pharmaceutical major Glenmark Pharmaceuticals has received the US Food and Drug Administration (USFDA) approval f...

April 28, 2017 | Friday | News
Asceneuron gets regulatory approval to initiate clinical trial of new drug candidate

Singapore: Asceneuron, an emerging leader in the development of innovative small molecules for neurodegenerative disease...

April 7, 2017 | Friday | News
Licensing agreement announced for sutezolid drug for TB

TB Alliance and Medicines Patent Pool announced a licensing agreement for the clinical development of sutezolid. It is a...

March 24, 2017 | Friday | News
Astex Pharma cancer drug receives US marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule thera...

March 14, 2017 | Tuesday | News
Chugai receives Taiwan nod for Alecensa

Singapore: Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan has re...

February 27, 2017 | Monday | News
TimeBlock - to reverse biological ageing launches in Singapore

For thousands of years, humans have been on a quest to combat the process of degenerative ageing and find the secret of ...

February 20, 2017 | Monday | News
Australia approves drug that can 'melt away' cancer cells

Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away...

January 10, 2017 | Tuesday | News
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin

Boehringer Ingelheim announced new data from the Phase I INVICTAN-1 study, which show that BI 695502, its bevacizumab bi...

November 23, 2016 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls